Cite
HARVARD Citation
Tijeras-Raballand, A. et al. (n.d.). Galunisertib combined with sorafenib affects in vivo tumor growth and immune landscape in hepatocellular carcinoma (HCC). European journal of cancer. pp. S133-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tijeras-Raballand, A. et al. (n.d.). Galunisertib combined with sorafenib affects in vivo tumor growth and immune landscape in hepatocellular carcinoma (HCC). European journal of cancer. pp. S133-. [Online].